Cellcentric

Developer of oral small molecule inhibitors for treating blood cancers

placeCambridge, England, United Kingdom calendar_todayFounded 2003 groups18 employees language cellcentric.com

Registered entities

Innovation

6 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing.

Social engagement

Social engagement: 6.6K social following, 5 posts in the last 12 months — below the industry typical range.

Recent activity

8 Jun 2026
Leadership hire
Chief Administrative Officer and U.S. General Counsel
4 Jun 2026
Event
EHA2026
27 May 2026
Product launch
mminovation.com
Coming soon